PRINT THIS PAGE US Prospect Venture Partners closes $500m fund10/12/2004. Source: AltAssets. 
 California-based Prospect Venture Partners has closed its third fund, Prospect Venture Partners III, comfortably ahead of target with commitments of $500m.
The fund's managing directors are Alex Barkas, Russell Hirsch, David Schnell and Jim Tananbaum. The partners have strong investment track records, having led investments in over 70 health care and biomedical companies from 1992 to 2004.
Prior fund Prospect Venture Partners II, also a $500m fund, was raised in 2001. It has invested in over 25 life science companies including Archemix, Gloucester Pharmaceuticals, Tercica and medical device companies Opus Medical and Visiogen.
Prospect Venture Partners has $1bn of capital under management. The firm invests in biomedical technology and life science companies.
Copyright © 2004 AltAssets
|
